Health Care
More on Health Care
Washington, D.C. (January 30, 2025)—Today, Rep. Gerald E. Connolly, Ranking Member of the Committee on Oversight and Government Reform, Rep. Jasmine Crockett, Vice Ranking Member of the Committee on Oversight and Government Reform, Rep. Summer Lee, Ranking Member of the Subcommittee on Federal Law Enforcement, and Rep.
Washington, D.C. (December 13, 2024)—Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, and Rep. Robert Garcia, Ranking Member of the Subcommittee on National Security, the Border, and Foreign Affairs, sent a letter to U.S.
Washington, D.C. (September 19, 2024)âBelow is Ranking Member Jamie Raskinâs opening statement at todayâs full committee hearing, for which Chairman Comer convened four witnesses with ties to the radical Project 2025 to audition for top jobs in a second Trump Administration
Washington, D.C. (July 24, 2024)—Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, led Committee Democrats in examining anticompetitive industry policies that increase prescription drug costs, hurt local pharmacies, and hinder patient care in a hearing with the nation’s three largest Pharmacy Benefit Managers (PBMs)—Express Scripts, CVS Caremark, and OptumRx.
Washington, D.C. (July 11, 2024)—Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, and Rep.
Washington, D.C. (May 16, 2024)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, sent letters to the five of the largest health insurers and four of the largest pharmacy benefit managers (PBMs), requesting information on how the companies plan to respond to revised federal guidance designed to improve no-cost access to birth control for millions of women across the country and urging the companies to implement this guidance.